Page last updated: 2024-12-11
synerazol
Description
synerazol: from Aspergillus fumigatus; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
Synonyms (3)
Synonym |
synerazol |
CHEMBL473144 |
(5s,8s,9r)-8-benzoyl-2-[(2s,3r)-3-[(z)-but-1-enyl]oxiran-2-yl]-9-hydroxy-8-methoxy-3-methyl-1-oxa-7-azaspiro[4.4]non-2-ene-4,6-dione |
Bioassays (5)
Assay ID | Title | Year | Journal | Article |
AID394967 | Inhibition of IL4 and LPS-induced IgE production in BALB/c mouse spleen B cell after 6 days by ELISA | 2009 | Bioorganic & medicinal chemistry letters, Mar-01, Volume: 19, Issue:5
| Pseurotin A and its analogues as inhibitors of immunoglobulin E [correction of immunoglobuline E] production. |
AID394968 | Immunosuppressive activity in rat lymphocytes assessed as inhibition of mixed-lymphocyte reaction | 2009 | Bioorganic & medicinal chemistry letters, Mar-01, Volume: 19, Issue:5
| Pseurotin A and its analogues as inhibitors of immunoglobulin E [correction of immunoglobuline E] production. |
AID394971 | Cytotoxicity against BALB/c mouse B cells assessed as cell viability | 2009 | Bioorganic & medicinal chemistry letters, Mar-01, Volume: 19, Issue:5
| Pseurotin A and its analogues as inhibitors of immunoglobulin E [correction of immunoglobuline E] production. |
AID394969 | Inhibition of PHA-induced BALB/c mouse T cell proliferation at 10 uM | 2009 | Bioorganic & medicinal chemistry letters, Mar-01, Volume: 19, Issue:5
| Pseurotin A and its analogues as inhibitors of immunoglobulin E [correction of immunoglobuline E] production. |
AID394970 | Cytotoxicity against human K562 cells | 2009 | Bioorganic & medicinal chemistry letters, Mar-01, Volume: 19, Issue:5
| Pseurotin A and its analogues as inhibitors of immunoglobulin E [correction of immunoglobuline E] production. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Research
Studies (6)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 5 (83.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |